Literature DB >> 15272312

Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.

Stefan Schulz1, Dana Mayer, Manuela Pfeiffer, Ralf Stumm, Thomas Koch, Volker Höllt.   

Abstract

Morphine is a poor inducer of micro-opioid receptor (MOR) internalization, but a potent inducer of cellular tolerance. Here we show that, in contrast to full agonists such as [D-Ala(2)-MePhe(4)-Gly-ol]enkephalin (DAMGO), morphine stimulated a selective phosphorylation of the carboxy-terminal residue 375 (Ser(375)). Ser(375) phosphorylation was sufficient and required for morphine-induced desensitization of MOR. In the presence of full agonists, morphine revealed partial agonistic properties and potently inhibited MOR phosphorylation and internalization. Upon removal of the drug, DAMGO-desensitized receptors were rapidly dephosphorylated. In contrast, morphine-desensitized receptors remained at the plasma membrane in a Ser(375)-phosphorylated state for prolonged periods. Thus, morphine promotes terminal MOR desensitization by inducing a persistent modification of Ser(375).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15272312      PMCID: PMC514508          DOI: 10.1038/sj.emboj.7600334

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  28 in total

1.  C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.

Authors:  T Koch; S Schulz; M Pfeiffer; M Klutzny; H Schröder; E Kahl; V Höllt
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

2.  Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization.

Authors:  R El Kouhen; A L Burd; L J Erickson-Herbrandson; C Y Chang; P Y Law; H H Loh
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

Review 3.  Under siege: The brain on opiates.

Authors:  E J Nestler
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

4.  Enhanced morphine analgesia in mice lacking beta-arrestin 2.

Authors:  L M Bohn; R J Lefkowitz; R R Gainetdinov; K Peppel; M G Caron; F T Lin
Journal:  Science       Date:  1999-12-24       Impact factor: 47.728

5.  Effects of orotic acid on the development of morphine tolerance.

Authors:  G Grecksch; T Ott; H Matthies
Journal:  Psychopharmacologia       Date:  1974-05-15

6.  The effect of intrinsic efficacy on opioid tolerance.

Authors:  A Duttaroy; B C Yoburn
Journal:  Anesthesiology       Date:  1995-05       Impact factor: 7.892

7.  Selectivity in the control of opiate receptor density in the animal and in cultured fetal brain cells.

Authors:  R Simantov; J Lotem; R Levy
Journal:  Neuropeptides       Date:  1984-12       Impact factor: 3.286

8.  A rapid and simple method for the quantitative determination of tolerance development to opiates in the guinea-pig ileum in vitro.

Authors:  A Rezvani; J P Huidobro-Toro; J Hu; E L Way
Journal:  J Pharmacol Exp Ther       Date:  1983-05       Impact factor: 4.030

9.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

10.  Morphine activates opioid receptors without causing their rapid internalization.

Authors:  D E Keith; S R Murray; P A Zaki; P C Chu; D V Lissin; L Kang; C J Evans; M von Zastrow
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

View more
  79 in total

Review 1.  Opioid receptor trafficking and signaling: what happens after opioid receptor activation?

Authors:  Jia-Ming Bian; Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2011-09-25       Impact factor: 5.046

2.  μ-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization.

Authors:  Jamie McPherson; Guadalupe Rivero; Myma Baptist; Javier Llorente; Suleiman Al-Sabah; Cornelius Krasel; William L Dewey; Chris P Bailey; Elizabeth M Rosethorne; Steven J Charlton; Graeme Henderson; Eamonn Kelly
Journal:  Mol Pharmacol       Date:  2010-07-20       Impact factor: 4.436

3.  Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling.

Authors:  Bo Feng; Zhihua Li; Jia Bei Wang
Journal:  Mol Pharmacol       Date:  2011-01-06       Impact factor: 4.436

4.  Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.

Authors:  Simona Patierno; Laura Anselmi; Ingrid Jaramillo; David Scott; Rachel Garcia; Catia Sternini
Journal:  Gastroenterology       Date:  2010-11-09       Impact factor: 22.682

5.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 6.  Functional selectivity of GPCR signaling in animals.

Authors:  Lei Zhou; Laura M Bohn
Journal:  Curr Opin Cell Biol       Date:  2013-12-22       Impact factor: 8.382

7.  Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation.

Authors:  Chad E Groer; Cullen L Schmid; Alex M Jaeger; Laura M Bohn
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

8.  PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor.

Authors:  Sreedhar Madishetti; Nadine Schneble; Christian König; Emilio Hirsch; Stefan Schulz; Jörg P Müller; Reinhard Wetzker
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 9.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

10.  Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

Authors:  Florian Pöll; Diana Lehmann; Susann Illing; Mihaela Ginj; Stefan Jacobs; Amelie Lupp; Ralf Stumm; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.